Disc Medicine (IRON) Tops Q3 EPS by 14c

Disc Medicine (NASDAQ: IRON) reported Q3 EPS of ($0.89), $0.14 better than the analyst estimate of ($1.03).

For earnings history and earnings-related data on Disc Medicine (IRON) click here.

You May Also Be Interested In

• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• Metalla Royalty & Streaming Ltd. (MTA) Reports In-Line Q2 EPS
• Dawson Geophysical (DWSN) Reports Q2 Loss of $0.11